V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220016346 | 220006222 | null | 63 | null | 2017-08-03 | 2017-08-04 | FLAG + Idarubicin | N | N | 220023625 | FLAG + IDARUBICIN |
| 220016347 | 220006223 | 1.85 | 85 | Curative (C) | 2015-10-28 | 2016-01-10 | FLAG + Idarubicin | null | N | 220023637 | FLAG + IDARUBICIN |
| 220016348 | 220006224 | null | 62 | Curative (C) | 2015-07-19 | 2015-07-20 | AML17 TRIAL | null | N | 220023640 | AML17 TRIAL |
| 220016349 | 220006228 | 1.8 | 89.1 | Curative (C) | 2013-08-29 | 2013-09-26 | AML17 TRIAL | N | N | 220023646 | AML17 TRIAL |
| 220016350 | 220013350 | 1.71 | 70.4 | Disease modification (D) | 2016-01-09 | 2016-01-11 | FLAG + Idarubicin | 02 | N | 220023647 | FLAG + IDARUBICIN |
| 220016351 | 220006235 | 1.31 | 55.4 | Curative (C) | 2016-10-19 | 2016-11-19 | AML17 TRIAL | Y | N | 220023662 | AML17 TRIAL |
| 220016352 | 220006236 | 1.76 | 66.5 | Curative (C) | 2014-04-07 | 2014-04-08 | AML17 TRIAL | 02 | N | 220023665 | AML17 TRIAL |
| 220016353 | 220013353 | 1.73 | 71.2 | Curative (C) | null | 2014-02-03 | FLAG + Idarubicin | null | N | 220023671 | FLAG + IDARUBICIN |
| 220016354 | 220006240 | 1.71 | 55.2 | Curative (C) | 2016-09-04 | 2016-09-04 | FLAG + Idarubicin | N | N | 220023676 | FLAG + IDARUBICIN |
| 220016355 | 220006242 | 1.78 | 83 | Curative (C) | 2013-08-03 | 2013-09-23 | FLAG + Idarubicin | N | N | 220023681 | FLAG + IDARUBICIN |
| 220016356 | 220006243 | 1.77 | 108 | Curative (C) | 2014-10-25 | 2014-12-06 | FLAG + Idarubicin | N | N | 220023681 | FLAG + IDARUBICIN |
| 220016357 | 220006244 | 1.68 | 49 | Curative (C) | 2015-09-25 | 2015-11-30 | AML17 TRIAL | N | N | 220023691 | AML17 TRIAL |
| 220016358 | 220006244 | 1.66 | 86.5 | Curative (C) | 2017-02-01 | 2017-02-01 | AML17 TRIAL | 2 | N | 220023691 | AML17 TRIAL |
| 220016359 | 220006246 | null | 125.4 | Curative (C) | 2016-06-06 | 2016-08-08 | FLAG + Idarubicin | 02 | N | 220023701 | FLAG + IDARUBICIN |
| 220016360 | 220006252 | 1.76 | 68 | Curative (C) | 2017-07-12 | 2017-07-12 | FLAG + Idarubicin | 2 | N | 220023725 | FLAG + IDARUBICIN |
| 220016361 | 220006255 | null | 66 | Curative (C) | 2013-06-29 | 2013-06-30 | FLAG + Idarubicin | N | null | 220023737 | FLAG + IDARUBICIN |
| 220016362 | 220006259 | 1.85 | 78 | null | 2014-03-26 | 2014-06-22 | AML17 TRIAL | Y | N | 220023739 | AML17 TRIAL |
| 220016364 | 220006262 | 1.76 | 92.2 | Not known (9) | 2016-12-29 | 2018-03-13 | AML17 TRIAL | N | N | 220023753 | AML17 TRIAL |
| 220016365 | 220013370 | 1.74 | 68 | Curative (C) | 2015-06-01 | 2015-07-23 | AML17 TRIAL | N | N | 220023759 | AML17 TRIAL |
| 220016367 | 220006267 | 1.88 | 81.4 | Curative (C) | null | 2016-10-10 | FLAG + Idarubicin | 02 | N | 220023778 | FLAG + IDARUBICIN |
| 220016368 | 220006269 | 1.79 | 120 | Curative (C) | 2013-08-14 | 2013-08-14 | AML17 TRIAL | 01 | N | 220023787 | AML17 TRIAL |
| 220016369 | 220006271 | 1.78 | 87.4 | Not known (9) | null | 2013-06-28 | AML17 TRIAL | N | N | 220023793 | AML17 TRIAL |
| 220016370 | 220006275 | 1.77 | 87.6 | Palliative (P) | 2014-07-30 | 2014-08-02 | FLAG + Idarubicin | 02 | N | 220023811 | FLAG + IDARUBICIN |
| 220016371 | 220013385 | 1.84 | 68.4 | Curative (C) | 2013-08-23 | 2013-10-31 | FLAG + Idarubicin | Y | N | 220023815 | FLAG + IDARUBICIN |
| 220016372 | 220006280 | 1.88 | 103 | Curative (C) | 2017-05-28 | 2017-07-15 | AML17 TRIAL | N | N | 220023821 | AML17 TRIAL |
| 220016373 | 220006283 | 1.83 | 73.4 | Curative (C) | 2016-08-31 | 2016-09-01 | AML17 TRIAL | 02 | N | 220023821 | AML17 TRIAL |
| 220016375 | 220006287 | null | 79 | Curative (C) | 2014-04-12 | 2014-07-11 | AML17 TRIAL | N | null | 220023833 | AML17 TRIAL |
| 220016376 | 220006292 | 1.92 | 73.9 | Curative (C) | null | 2017-09-22 | AML Interim Guidelines FLAG-Ida | 99 | N | 220023849 | FLAG + IDARUBICIN |
| 220016377 | 220006294 | 1.57 | 77.9 | Curative (C) | 2016-09-18 | 2016-12-26 | AML17 TRIAL | N | N | 220023866 | AML17 TRIAL |
| 220016378 | 220006299 | 1.87 | 87.7 | Curative (C) | 2017-09-12 | 2017-09-16 | AML Interim Guidelines FLAG-Ida | N | N | 220023873 | FLAG + IDARUBICIN |
| 220016379 | 220006300 | 1.66 | 57.4 | Curative (C) | 2017-04-05 | 2017-04-06 | AML17 TRIAL | N | N | 220023873 | AML17 TRIAL |
| 220016380 | 220006303 | 1.85 | 49.9 | Curative (C) | 2016-10-17 | 2017-02-09 | FLAG + Idarubicin | N | N | 220023888 | FLAG + IDARUBICIN |
| 220016381 | 220006305 | 1.86 | null | Not known (9) | 2017-10-09 | 2017-11-17 | AML17 TRIAL | Y | N | 220023893 | AML17 TRIAL |
| 220016382 | 220006307 | 1.75 | 69 | Curative (C) | 2013-12-21 | 2013-12-28 | FLAG + Idarubicin | N | N | 220023897 | FLAG + IDARUBICIN |
| 220016383 | 220013406 | null | 80.4 | Adjuvant (A) | 2018-03-23 | 2018-06-27 | FLAG + Idarubicin | Y | N | 220023923 | FLAG + IDARUBICIN |
| 220016384 | 220006312 | 1.54 | 87.7 | Curative (C) | 2015-04-16 | 2015-04-16 | FLAG + Idarubicin | 02 | null | 220023923 | FLAG + IDARUBICIN |
| 220016385 | 220021437 | 1.6 | 62.6 | Curative (C) | 2016-04-27 | 2019-05-02 | AML17 TRIAL | N | N | 220023932 | AML17 TRIAL |
| 220016386 | 220006314 | null | 66.7 | Palliative (P) | 2014-04-22 | 2014-04-22 | AML17 TRIAL | N | N | 220023933 | AML17 TRIAL |
| 220016387 | 220006316 | 1.5 | 86.5 | Curative (C) | 2016-11-20 | 2016-11-20 | AML17 TRIAL | N | null | 220023938 | AML17 TRIAL |
| 220016388 | 220013412 | 1.55 | null | Palliative (P) | 2017-06-27 | 2017-07-30 | AML17 TRIAL | Y | N | 220023939 | AML17 TRIAL |
| 220016389 | 220013414 | 1.85 | 78 | Curative (C) | 2015-01-26 | 2015-08-29 | AML17 TRIAL | 2 | N | 220023946 | AML17 TRIAL |
| 220016390 | 220006321 | 1.56 | 70.6 | Curative (C) | 2013-04-18 | 2013-05-23 | AML17 TRIAL | N | null | 220023959 | AML17 TRIAL |
| 220016391 | 220021438 | 1.84 | 115.2 | Disease modification (D) | 2017-05-14 | 2017-05-14 | FLAG + Idarubicin | 02 | N | 220023967 | FLAG + IDARUBICIN |
| 220016392 | 220006324 | 1.78 | null | Adjuvant (A) | 2017-12-05 | 2017-12-05 | AML17 TRIAL | 01 | N | 220023975 | AML17 TRIAL |
| 220016393 | 220006324 | 1.78 | 78.8 | Curative (C) | 2016-03-14 | 2016-03-14 | AML17 TRIAL | 02 | N | 220023975 | AML17 TRIAL |
| 220016394 | 220006326 | 1.85 | 68.4 | Not known (9) | null | 2019-05-26 | FLAG + Idarubicin | N | null | 220023982 | FLAG + IDARUBICIN |
| 220016395 | 220006328 | 1.83 | 77.8 | Curative (C) | null | 2017-10-30 | FLAG + Idarubicin | null | N | 220023988 | FLAG + IDARUBICIN |
| 220016396 | 220006329 | 1.84 | 77.4 | Not known (9) | 2016-06-28 | 2016-06-28 | AML17 TRIAL | 01 | N | 220024000 | AML17 TRIAL |
| 220016399 | 220006332 | 1.71 | 83.5 | Curative (C) | 2018-04-09 | 2018-04-12 | FLAG + Idarubicin | 01 | N | 220024004 | FLAG + IDARUBICIN |
| 220016400 | 220006334 | 0 | 44.3 | Not known (9) | 2016-10-19 | 2016-10-26 | AML17 TRIAL | null | N | 220024028 | AML17 TRIAL |